# Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

> **NCT04440189** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **GID BIO, Inc.** · enrollment: 114 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DEVICE:** GID SVF-2 Device System

## Key facts

- **NCT ID:** NCT04440189
- **Lead sponsor:** GID BIO, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-15
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04440189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04440189, "Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04440189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*